p53 Antibody, Biotin conjugate (DO-7)

p53 Monoclonal Antibody for Western blot, IHC (P), IP

>> See 39 other antibodies for TP53 (antigen NY-CO-13, cellular tumor antigen p53, p53 tumor suppressor, phosphoprotein p53, transformation-related protein 53, TP53)
Synonyms:
antigen NY-CO-13, cellular tumor antigen p53, p53 tumor suppressor, phosphoprotein p53, transformation-related protein 53, TP53
Entrez Gene ID:
UniProt ID:
Details
Host / Isotype: Mouse / IgG2b, kappa
Class: Monoclonal
Type: Antibody
Clone: DO-7
Label: Biotin
Tested Species Reactivity: Human (Hu), Bovine (Bv), Non-human primate (Nhp)
Published Species Reactivity: Human (Hu), Mouse (Ms)
Immunogen: Recombinant human wild-type p53 protein expressed in E. coli
Ordering Information
Pierce p53 Antibody, Biotin conjugate (DO-7)
Product #
MA5-12554
Size
500 ul
Price
$360.00
Purchase
Add p53 Antibody, Biotin conjugate (DO-7) to your cart.
Tested Applications Dilution *
Western Blot (WB) 1:50-1:200
Immunohistochemistry (Paraffin) (IHC (P)) 1:100-1:200
Immunoprecipitation (IP) 1:50-1:100
Published Applications Dilution
Western Blot (WB) See publications below
Immunohistochemistry (IHC) See publications below
Immunoprecipitation (IP) See publications below
* Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own experiment using appropriate negative and positive controls.
Form Information
Form: Liquid
Concentration: 0.2mg/ml
Purification: Protein A
Storage Buffer: PBS, pH 7.4, with 0.2% BSA
Preservative: 0.09% sodium azide
Storage Conditions: 4° C
Product Specific Information
MA5-12554 targets p53 in IHC (P), IP, and WB applications and shows reactivity with Bovine, Human, and Non-human primate samples.

The MA5-12554 immunogen is recombinant human wild-type p53 protein expressed in E. coli.
General Information
This gene encodes a tumor suppressor protein containing transcriptional activation, DNA binding, and oligomerization domains. The encoded protein responds to diverse cellular stresses to regulate expression of target genes, thereby inducing cell cycle arrest, apoptosis, senescence, DNA repair, or changes in metabolism. Mutations in this gene are associated with a variety of human cancers, including hereditary cancers such as Li-Fraumeni syndrome. Alternative splicing of this gene and the use of alternate promoters result in multiple transcript variants and isoforms. Additional isoforms have also been shown to result from the use of alternate translation initiation codons
Product Images
  • p53 Antibody (MA5-12554) in WB
    MA5-12554_WesternBlot.jpg

    Western Blot with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554) (MA5-12554_WesternBlot.jpg)

    Western Blot with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554)

    Western blot of p53 using p53 Monoclonal Antibody (MA5-12554) on SKBR3 Cells.
  • p53 Antibody (MA5-12554) in IHC
    MA5-12554_Immunohistochemistry.jpg

    Immunohistochemistry with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554) (MA5-12554_Immunohistochemistry.jpg)

    Immunohistochemistry with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554)

    Formalin-fixed, paraffin-embedded human colon carcinoma stained with p53 antibody using peroxidase-conjugate and DAB chromogen. Note nuclear staining of tumor cells.
  • p53 Antibody (MA5-12554) in IP
    MA5-12554_Immunoprecipitation.jpg

    Immunoprecipitation with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554) (MA5-12554_Immunoprecipitation.jpg)

    Immunoprecipitation with anti-p53 Monoclonal Antibody [DO-7], Biotin conjugate (MA5-12554)

    Immunoprecipitation of p53 using p53 Monoclonal Antibody (MA5-12554) on denatured Human MDA231 Cells.
Publications:
Western Blot
  Species / Dilution Summary
  Hu / Not Cited
MA5-12554 was used in immunoprecipitation and western blot to investigate HCCR-2 expression in human cancers and its role in tumorigenesis

Oncogene. 2003 Jul 24;22(30):4679-89.
"Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization."
Author(s): Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY, Kim IK, Namkoong SE, Kim JW
Number of Citations: 1
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry and western blot to investigate the influence of human papillomavirus 16 infection on cellular immune response to squamous cell carcinoma of the head and neck

Clin Cancer Res. 2004 Oct 15;10(20):6929-37.
"Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck."
Author(s): Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
MA5-12554 was used in western blot to investigate the role of CDK2 in the MYCN over-expressing cancer cells

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12968-73.
"Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells."
Author(s): Molenaar JJ, Ebus ME, Geerts D, Koster J, Lamers F, Valentijn LJ, Westerhout EM, Versteeg R, Caron HN
Number of Citations: 7
(See PubMed article )
  Ms / 1:1000
MA5-12554 was used in western blot to investigate the effect of glutathione on chromosome aberrations, cell cycle kinetics, and cell cycle regulator proteins

Int J Radiat Biol. 2007 May;83(5):347-54.
"Influence of glutathione on the induction of chromosome aberrations, delay in cell cycle kinetics and cell cycle regulator proteins in irradiated mouse bone marrow cells."
Author(s): Ray S, Chatterjee A
Number of Citations: 1
(See PubMed article )
Immunohistochemistry
  Species / Dilution Summary
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to investigate the correlation of p53 and Ki-67 with the recurrence and progression of superficial urothelial cell carcinomas of urinary bladder

Pathol Int. 2002 Jul;52(7):463-9.
"Impact of p53 and Ki-67 in predicting recurrence and progression of superficial (pTa and pT1) urothelial cell carcinomas of urinary bladder."
Author(s): Kilicli-Camur N, Kilicaslan I, Gulluoglu MG, Esen T, Uysal V
Number of Citations: 0
(See PubMed article )
  Hu / 1:200
MA5-12554 was used in immunohistochemistry to investigate the beta-catenin pathway in non-melanoma skin tumors

Am J Pathol. 2003 Dec;163(6):2277-87.
"Alterations of beta-catenin pathway in non-melanoma skin tumors: loss of alpha-ABC nuclear reactivity correlates with the presence of beta-catenin gene mutation."
Author(s): Doglioni C, Piccinin S, Demontis S, Cangi MG, Pecciarini L, Chiarelli C, Armellin M, Vukosavljevic T, Boiocchi M, Maestro R
Number of Citations: 1
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to study the molecular determinants of the response to radiotherapy in oral carcinoma

Int J Cancer. 2004 May 1;109(5):710-6.
"p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma."
Author(s): Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari KR, Abraham T, Abraham EK, Nair MK
Number of Citations: 2
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to report on a case of paratesticular clear cell carcinoma of the tunica vaginalis of the testis

Pathol Int. 2004 Aug;54(8):641-7.
"Clear cell adenocarcinoma of the tunica vaginalis of the testis with an adjacent uterus-like tissue."
Author(s): Tulunay O, Gögü? C, Baltaci S, Bulut S
Number of Citations: 0
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry and western blot to investigate the influence of human papillomavirus 16 infection on cellular immune response to squamous cell carcinoma of the head and neck

Clin Cancer Res. 2004 Oct 15;10(20):6929-37.
"Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck."
Author(s): Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL
Number of Citations: 1
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to investigate the prognostic significance of p21waf1/cip1 expression in oral squamous cell carcinoma

J Oral Pathol Med. 2005 May;34(5):274-9.
"p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma."
Author(s): Nemes JA, Nemes Z, Márton IJ
Number of Citations: 1
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to study the role of Ki-67, p53, estrogen and progesterone receptors in uterine leiomyosarcomas

Gynecol Oncol. 2005 Oct;99(1):36-42.
"The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study."
Author(s): Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S
Number of Citations: 5
(See PubMed article )
  Hu / 1:50
MA5-12554 was used in immunohistochemistry to evaluate the prognostic value of p53 expression in stage III non-small cell lung cancer

Anticancer Res. 2005 May-Jun;25(3c):2385-9.
"Prognostic role of p53 in stage III non-small cell lung cancer."
Author(s): Berghmans T, Mascaux C, Martin B, Ninane V, Sculier JP
Number of Citations: 1
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry The report on a patient with pulmonary large cell carcinoma with rhabdoid phenotype

Ann Diagn Pathol. 2005 Aug;9(4):223-6.
"Pulmonary large cell carcinoma with rhabdoid phenotype."
Author(s): Yilmazbayhan D, Ates LE, Dilege S, Gulluoglu M, Tanju S, Kalayci G
Number of Citations: 0
(See PubMed article )
  Hu / 2 ug/ml
MA5-12554 was used in immunohistochemistry to investigate the presence and utility of p53 antibodies in patients with breast cancer

Breast Cancer Res Treat. 2005 Sep;93(2):111-5.
"The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters."
Author(s): Gao RJ, Bao HZ, Yang Q, Cong Q, Song JN, Wang L
Number of Citations: 1
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to study the role of survivin in pre-invasive lesions and non-small cell lung carcinoma

Virchows Arch. 2006 Aug;449(2):164-70.
"Survivin expression in pre-invasive lesions and non-small cell lung carcinoma."
Author(s): Akyürek N, Memi? L, Ekinci O, Köktürk N, Oztürk C
Number of Citations: 6
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to report on a case of myointimoma of the glans penis

Pathol Int. 2007 Mar;57(3):158-61.
"Myointimoma of the glans penis."
Author(s): Vardar E, Gunlusoy B, Arslan M, Kececi S
Number of Citations: 0
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to study potential prognostic markers in Hungarian breast cancer patients

Anticancer Res. 2007 Jan-Feb;27(1A):279-82.
"Prognostic factors in Hungarian breast cancer patients."
Author(s): Nádasi E, Anga B, Sándor J, Megyesi J, Kelemen D, Mottolese M, Natali PG, Hegedus G, Arany I, Ember I
Number of Citations: 0
(See PubMed article )
  Hu / 1:50
MA5-12554 was used in immunohistochemistry to report on a morphological and molecular analysis of two cases of Villoglandular adenocarcinoma of the cervix

Int J Gynecol Pathol. 2007 Apr;26(2):199-204.
"Villoglandular adenocarcinoma of the cervix: two new cases with morphological and molecular study."
Author(s): Giordano G, D'Adda T, Gnetti L, Merisio C, Gabrielli M, Melpignano M
Number of Citations: 2
(See PubMed article )
  Hu / Not Cited
MA5-12554 was used in immunohistochemistry to investigate the efficacy of p53 therapy in Li-Fraumeni syndrome

Mol Cancer Ther. 2007 May;6(5):1478-82.
"p53 therapy in a patient with Li-Fraumeni syndrome."
Author(s): Senzer N, Nemunaitis J, Nemunaitis M, Lamont J, Gore M, Gabra H, Eeles R, Sodha N, Lynch FJ, Zumstein LA, Menander KB, Sobol RE, Chada S
Number of Citations: 4
(See PubMed article )
  Hu / 1:25
MA5-12554 was used in immunohistochemistry to report on a case of transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor

Int J Gynecol Pathol. 2007 Jul;26(3):298-304.
"Transitional cell carcinoma of the endometrium associated with benign ovarian brenner tumor: a case report with immunohistochemistry molecular analysis and a review of the literature."
Author(s): Giordano G, D'Adda T, Gnetti L, Merisio C, Raboni S
Number of Citations: 0
(See PubMed article )
  Hu / 1:200
MA5-12554 was used in immunohistochemistry to study the diagnostic and prognostic value of cell cycle regulators in differentiated thyroid cancer

Ann Surg Oncol. 2007 Dec;14(12):3403-11.
"Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer."
Author(s): Melck A, Masoudi H, Griffith OL, Rajput A, Wilkins G, Bugis S, Jones SJ, Wiseman SM
Number of Citations: 3
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to study the prognostic value of different PIK3CA gene mutations in breast cancer

Clin Cancer Res. 2007 Oct 15;13(20):6064-9.
"Different prognostic roles of mutations in the helical and kinase domains of the PIK3CA gene in breast carcinomas."
Author(s): Barbareschi M, Buttitta F, Felicioni L, Cotrupi S, Barassi F, Del Grammastro M, Ferro A, Dalla Palma P, Galligioni E, Marchetti A
Number of Citations: 20
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to perform immunohistochemical studies of apocrine carcinomas in Turkish women with breast cancer

Pathol Res Pract. 2008;204(6):367-71.
"Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression."
Author(s): Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB
Number of Citations: 1
(See PubMed article )
  Hu / 1:50
MA5-12554 was used in immunohistochemistry to examine the diagnostic significance of p53 protein in the tumorigenesis in biliopancreatic tree

Dig Dis Sci. 2009 Apr;54(4):789-92.
"Immunocytochemical assessment of p53 protein to detect malignancy in increased cell-yield brush cytology from the biliopancreatic tree."
Author(s): Villanacci V, Cestari R, Giulini S, Cengia P, Missale G, Berenzi A, Rossi E, Bonardi M, Baiocchi L, Bassotti G
Number of Citations: 1
(See PubMed article )
  Hu / 1:50
MA5-12554 was used in immunohistochemistry to investigate the expression of some histopathological and immunohistochemical markers in sudden cardiac death

Rom J Morphol Embryol. 2008;49(3):315-20.
"Immunophenotypical pleomorphism expression in sudden cardiac death."
Author(s): Ceau?u M, Curc? C, Ardeleanu C, Dermengiu D
Number of Citations: 0
(See PubMed article )
  Hu / Not Cited
MA5-12554 was used in immunohistochemistry to investigate the expression of mammalian actin regulatory protein Ena in colorectal lesions

Rom J Morphol Embryol. 2008;49(3):345-9.
"The expression of cytoskeleton regulatory protein Mena in colorectal lesions."
Author(s): Gurzu S, Jung I, Prantner I, Ember I, Pávai Z, Mezei T
Number of Citations: 7
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to investigate the gene events of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia and their correlation with disease progression and prognosis

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3179-87.
"Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia."
Author(s): Kresty LA, Mallery SR, Knobloch TJ, Li J, Lloyd M, Casto BC, Weghorst CM
Number of Citations: 1
(See PubMed article )
  Hu / Not Cited
MA5-12554 was used in immunohistochemistry to examine the prognostic significance of multiple genes in osteosarcoma

Acta Orthop Traumatol Turc. 2009 Jan-Feb;43(1):28-34.
"[The effect of resistance-related proteins on the prognosis and survival of patients with osteosarcoma: an immunohistochemical analysis]."
Author(s): Ozger H, Eralp L, Atalar AC, Toker B, Esberk Ate? L, Sungur M, Bilgiç B, Ayan I
Number of Citations: 1
(See PubMed article )
  Hu / 1:200
MA5-12554 was used in immunohistochemistry to investigate the association of Axin expression with non-small-cell lung cancer apoptosis induced by X-radiation

Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):518-26.
"X-radiation induces non-small-cell lung cancer apoptosis by upregulation of Axin expression."
Author(s): Han Y, Wang Y, Xu HT, Yang LH, Wei Q, Liu Y, Zhang Y, Zhao Y, Dai SD, Miao Y, Yu JH, Zhang JY, Li G, Yuan XM, Wang EH
Number of Citations: 3
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to investigate the expression of specific genes in resected adenocarcinoma of lung

Cancer. 2010 Feb 1;116(3):676-85.
"Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray."
Author(s): Kim HS, Park YH, Lee J, Ahn JS, Kim J, Shim YM, Kim JH, Park K, Han J, Ahn MJ
Number of Citations: 1
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to compare expression of Maspin, VEGF, and p53 between carcinomas

Pathol Oncol Res. 2010 Dec;16(4):553-61.
"Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters."
Author(s): Bircan A, Bircan S, Kapucuoglu N, Songur N, Ozturk O, Akkaya A
Number of Citations: 0
(See PubMed article )
  Hu / 1:1000
MA5-12554 was used in immunohistochemistry to investigate the relationship of p53 expression with DNA aneuploidy in vulva malignancies

Hum Pathol. 2010 Oct;41(10):1475-85.
"High levels of p53 expression correlate with DNA aneuploidy in (pre)malignancies of the vulva."
Author(s): van der Avoort IA, van de Nieuwenhof HP, Otte-Höller I, Nirmala E, Bulten J, Massuger LF, van der Laak JA, Slootweg PJ, de Hullu JA, van Kempen LC
Number of Citations: 1
(See PubMed article )
  Hu / 1:100
MA5-12554 was used in immunohistochemistry to report on a case of papillary carcinoma with diffuse papillomatosis of the gallbladder and cystic duct

Ann Diagn Pathol. 2011 Apr;15(2):140-4.
"Papillary carcinoma with diffuse papillomatosis of gallbladder and cystic duct."
Author(s): Kosemehmetoglu K, Akpinar E, Sokmensuer C, Hamaloglu E
Number of Citations: 0
(See PubMed article )
  Hu / 1:500
MA5-12554 was used in immunohistochemistry to investigate the secretion of anti-diuretic hormone in neuroblastoma

Endocr Pathol. 2010 Dec;21(4):266-73.
"Primary sellar neuroblastoma presenting with syndrome of inappropriate secretion of anti-diuretic hormone."
Author(s): Radotra B, Apostolopoulos V, Sandison A, Hatfield EC, Mendoza N, Moss J, Mehta A, Glaser M, Meeran K, Roncaroli F
Number of Citations: 1
(See PubMed article )
  Hu / 1:300
MA5-12554 was used in immunohistochemistry to investigate the effect of galectin-3 and heparanase on the pathogenesis of endometrial carcinomas

Arch Gynecol Obstet. 2011 Nov;284(5):1231-9.
"Investigation of galectin-3 and heparanase in endometrioid and serous carcinomas of the endometrium and correlation with known predictors of survival."
Author(s): Ege CB, Akbulut M, Zekio?lu O, Ozdemir N
Number of Citations: 1
(See PubMed article )
  Hu / 0
MA5-12554 was used in immunohistochemistry to investigate esophageal function and its relationship with gastroesophageal reflux disease and Barrett esophagus in patients with cervical inlet patch

Dis Esophagus. 2011 Nov 22;():.
"Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch."
Author(s): Rosztóczy A, Izbéki F, Németh IB, Dulic S, Vadászi K, Róka R, Gecse K, Gyökeres T, Lázár G, Tiszlavicz L, Wittmann T
Number of Citations: 1
(See PubMed article )
  Hu / 1:1500
MA5-12554 was used in immunohistochemistry to study a case of primary squamous cell carcinoma of the thyroid

Pathol Int. 2012 Jan;62(1):43-8.
"Primary pure squamous cell carcinoma of the thyroid: report and histogenic consideration of a case involving a BRAF mutation."
Author(s): Ko YS, Hwang TS, Han HS, Lim SD, Kim WS, Oh SY
Number of Citations: 1
(See PubMed article )
  Hu / 1:250
MA5-12554 was used in immunohistochemistry to investigate the relation between endometrial intraepithelial carcinoma and serous ovarian carcinoma

Int J Gynecol Cancer. 2012 Mar;22(3):457-64.
"Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?"
Author(s): Roelofsen T, van Kempen LC, van der Laak JA, van Ham MA, Bulten J, Massuger LF
Number of Citations: 1
(See PubMed article )
Immunoprecipitation
  Species / Dilution Summary
  Hu / Not Cited
MA5-12554 was used in immunoprecipitation and western blot to investigate HCCR-2 expression in human cancers and its role in tumorigenesis

Oncogene. 2003 Jul 24;22(30):4679-89.
"Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization."
Author(s): Ko J, Lee YH, Hwang SY, Lee YS, Shin SM, Hwang JH, Kim J, Kim YW, Jang SW, Ryoo ZY, Kim IK, Namkoong SE, Kim JW
Number of Citations: 1
(See PubMed article )
  Hu / 2 ug/ml
MA5-12554 was used in immunoprecipitation to study the role of the p53 target gene FLJ11259/DRAM encoding a novel transmembrane protein

Biochim Biophys Acta. 2007 Apr;1769(4):209-19.
"The direct p53 target gene, FLJ11259/DRAM, is a member of a novel family of transmembrane proteins."
Author(s): Kerley-Hamilton JS, Pike AM, Hutchinson JA, Freemantle SJ, Spinella MJ
Number of Citations: 6
(See PubMed article )
(This product is for In Vitro experimental use only. Not for resale without express authorization.)
Part of Thermo Fisher Scientific